Standard
African AI Lab’s Experiment Exposes Vulnerabilities in Drug Discovery Models and Sparks Global Biosecurity Debate
Out of scientific curiosity and an urgent drive to understand the boundaries of modern technology, researchers at a small artificial intelligence laboratory in Accra, Ghana, made a consequential decision in 2024: they removed the guardrails from their proprietary drug discovery AI model. Instead of asking it to help cure disease, they instructed it to design…
